• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA.由重组痘苗病毒 Ankara(MVA)表达的 HIV 包膜糖蛋白(Env)的自发截短所导致的增强的细胞表面表达、免疫原性和遗传稳定性。
Virology. 2008 Mar 15;372(2):260-72. doi: 10.1016/j.virol.2007.10.033. Epub 2007 Nov 28.
2
Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus.采用 DNA、改良安卡拉痘苗病毒和基于蛋白的疫苗进行初免-加强免疫可诱导针对 CAP256 超感染病毒的强效 HIV-1 2 型中和抗体。
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.02155-18. Print 2019 Apr 15.
3
Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways.通过删除阻断干扰素信号通路的痘苗病毒基因(C6L和K7R)来改善HIV/AIDS候选疫苗MVA-B的适应性免疫和记忆免疫反应
PLoS One. 2013 Jun 27;8(6):e66894. doi: 10.1371/journal.pone.0066894. Print 2013.
4
Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes.基于流感病毒和痘苗病毒载体的初免-加强免疫方案可增强全身及生殖泌尿引流淋巴结中针对人类免疫缺陷病毒Env蛋白的细胞免疫反应。
J Virol. 2003 Jun;77(12):7048-57. doi: 10.1128/jvi.77.12.7048-7057.2003.
5
Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigens.缺失编码 IRF3 抑制剂的牛痘病毒 N2L 基因可提高表达 HIV-1 抗原的改良安卡拉牛痘病毒的免疫原性。
J Virol. 2014 Mar;88(6):3392-410. doi: 10.1128/JVI.02723-13. Epub 2014 Jan 3.
6
A Novel MVA-Based HIV Vaccine Candidate (MVA-gp145-GPN) Co-Expressing Clade C Membrane-Bound Trimeric gp145 Env and Gag-Induced Virus-Like Particles (VLPs) Triggered Broad and Multifunctional HIV-1-Specific T Cell and Antibody Responses.一种新型基于 MVA 的 HIV 疫苗候选物(MVA-gp145-GPN),共表达 C 型膜结合三聚体 gp145Env 和 Gag 诱导的病毒样颗粒(VLPs),引发广泛的多功能 HIV-1 特异性 T 细胞和抗体反应。
Viruses. 2019 Feb 16;11(2):160. doi: 10.3390/v11020160.
7
Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.用表达人免疫缺陷病毒89.6包膜蛋白的复制缺陷型重组痘苗病毒经直肠内免疫诱导黏膜细胞毒性T淋巴细胞反应。
J Virol. 1998 Oct;72(10):8264-72. doi: 10.1128/JVI.72.10.8264-8272.1998.
8
Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines.重组安卡拉痘苗病毒HIV疫苗的免疫原性与体外表达水平的相关性
Vaccine. 2008 Jan 24;26(4):486-93. doi: 10.1016/j.vaccine.2007.11.036. Epub 2007 Dec 3.
9
Mucosal immunization of lactating female rhesus monkeys with a transmitted/founder HIV-1 envelope induces strong Env-specific IgA antibody responses in breast milk.经粘膜免疫接种传播/原始 HIV-1 包膜的哺乳期恒河猴可诱导母乳中强烈的 Env 特异性 IgA 抗体应答。
J Virol. 2013 Jun;87(12):6986-99. doi: 10.1128/JVI.00528-13. Epub 2013 Apr 17.
10
Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.增强重组痘苗病毒天坛株(MVA)免疫反应:利用表达Env以及细胞因子白细胞介素-12(IL-12)和干扰素-γ(IFN-γ)的MVA和DNA载体增强对HIV-1的免疫反应。
Virus Res. 2006 Mar;116(1-2):11-20. doi: 10.1016/j.virusres.2005.08.008. Epub 2005 Oct 7.

引用本文的文献

1
Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passages.在重组改良安卡拉牛痘病毒载体中敲低转基因表达可提高遗传稳定性和多次传代过程中持续的转基因维持。
Front Immunol. 2024 Feb 6;15:1338492. doi: 10.3389/fimmu.2024.1338492. eCollection 2024.
2
Post-genomic era in agriculture and veterinary science: successful and proposed application of genetic targeting technologies.农业和兽医学中的后基因组时代:基因靶向技术的成功应用及应用设想
Front Vet Sci. 2023 Aug 3;10:1180621. doi: 10.3389/fvets.2023.1180621. eCollection 2023.
3
Antagonism of Protein Kinase R by Large DNA Viruses.大型DNA病毒对蛋白激酶R的拮抗作用。
Pathogens. 2022 Jul 12;11(7):790. doi: 10.3390/pathogens11070790.
4
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector.基于复制缺陷型黄病毒载体的重组 HIV-1 候选疫苗。
Sci Rep. 2019 Dec 27;9(1):20005. doi: 10.1038/s41598-019-56550-4.
5
HIV/AIDS Vaccines: 2018.艾滋病疫苗:2018 年。
Clin Pharmacol Ther. 2018 Dec;104(6):1062-1073. doi: 10.1002/cpt.1208. Epub 2018 Oct 9.
6
Virus-Like-Vaccines against HIV.抗HIV的病毒样疫苗
Vaccines (Basel). 2018 Feb 11;6(1):10. doi: 10.3390/vaccines6010010.
7
CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development.CRISPR/Cas9-推动正痘病毒基因组编辑用于疫苗和载体开发。
Viruses. 2018 Jan 22;10(1):50. doi: 10.3390/v10010050.
8
Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization.HIV-1 包膜表面表达增加与牛痘疫苗接种/蛋白加强免疫中的抗体反应改善相关。
Virology. 2018 Jan 15;514:106-117. doi: 10.1016/j.virol.2017.10.013. Epub 2017 Nov 22.
9
Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?安卡拉痘苗病毒载体的危害特征:有哪些知识空白?
Viruses. 2017 Oct 29;9(11):318. doi: 10.3390/v9110318.
10
HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site.HIV传播/奠基疫苗可引发针对CD4结合位点的自体2级中和抗体。
PLoS One. 2017 Oct 11;12(10):e0177863. doi: 10.1371/journal.pone.0177863. eCollection 2017.

本文引用的文献

1
Avidity of CD8 T cells sharpens immunodominance.CD8 T细胞的亲和力增强免疫显性。
Int Immunol. 2007 Apr;19(4):497-507. doi: 10.1093/intimm/dxm016. Epub 2007 Mar 21.
2
A conserved dileucine motif mediates clathrin and AP-2-dependent endocytosis of the HIV-1 envelope protein.一个保守的双亮氨酸基序介导HIV-1包膜蛋白的网格蛋白和AP-2依赖性内吞作用。
Mol Biol Cell. 2007 Feb;18(2):414-25. doi: 10.1091/mbc.e06-06-0535. Epub 2006 Nov 15.
3
HIV vaccines.艾滋病毒疫苗
Annu Rev Immunol. 2006;24:227-55. doi: 10.1146/annurev.immunol.24.021605.090605.
4
Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers.1型人类免疫缺陷病毒(HIV-1)DNA疫苗和改良安卡拉病毒载体疫苗单独及采用初免-加强免疫方案对健康未感染HIV-1志愿者进行I期临床试验的安全性
Vaccine. 2006 Jan 23;24(4):417-25. doi: 10.1016/j.vaccine.2005.08.041. Epub 2005 Aug 24.
5
Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail.通过gp41胞质尾部的膜相互作用结构域对1型人类免疫缺陷病毒包膜糖蛋白融合的调控。
J Virol. 2005 Oct;79(19):12231-41. doi: 10.1128/JVI.79.19.12231-12241.2005.
6
Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption.使用表达重组HIV-1 nef的痘苗病毒安卡拉(MVA)对接受高效抗逆转录病毒治疗(HAART)的HIV-1感染患者进行治疗性疫苗接种:安全性、免疫原性及对治疗中断期间病毒载量的影响
Antivir Ther. 2005;10(2):285-300.
7
Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines.不同的免疫反应模式,但改良痘苗病毒安卡拉(MVA)和DNA/MVA疫苗对猿猴-人类免疫缺陷病毒89.6P黏膜攻击具有相似的控制作用。
J Virol. 2002 Aug;76(15):7625-31. doi: 10.1128/jvi.76.15.7625-7631.2002.
8
Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine.Env以及Gag-Pol在DNA初免/重组改良安卡拉痘苗病毒疫苗控制猿猴-人类免疫缺陷病毒89.6P攻击中的关键作用。
J Virol. 2002 Jun;76(12):6138-46. doi: 10.1128/jvi.76.12.6138-6146.2002.
9
Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model.在恒河猴SHIV模型中,使用重组env - gag - pol痘苗病毒安卡拉(MVA)疫苗策略并辅以或不辅以寡聚Env蛋白加强免疫的比较。
Virology. 2002 Mar 15;294(2):270-81. doi: 10.1006/viro.2001.1345.
10
Immunization with recombinant modified vaccinia virus Ankara can modify mucosal simian immunodeficiency virus infection and delay disease progression in macaques.用重组改良安卡拉痘苗病毒免疫可改变猕猴黏膜感染猿猴免疫缺陷病毒的情况并延缓疾病进展。
J Gen Virol. 2002 Apr;83(Pt 4):807-818. doi: 10.1099/0022-1317-83-4-807.

由重组痘苗病毒 Ankara(MVA)表达的 HIV 包膜糖蛋白(Env)的自发截短所导致的增强的细胞表面表达、免疫原性和遗传稳定性。

Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA.

作者信息

Wyatt Linda S, Belyakov Igor M, Earl Patricia L, Berzofsky Jay A, Moss Bernard

机构信息

Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Virology. 2008 Mar 15;372(2):260-72. doi: 10.1016/j.virol.2007.10.033. Epub 2007 Nov 28.

DOI:10.1016/j.virol.2007.10.033
PMID:18048074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2289778/
Abstract

During propagation of modified vaccinia virus Ankara (MVA) encoding HIV 89.6 Env, a few viral foci stained very prominently. Virus cloned from such foci replicated to higher titers than the parent and displayed enhanced genetic stability on passage. Sequence analysis showed a single nucleotide deletion in the 89.6 env gene of the mutant that caused a frame shift and truncation of 115 amino acids from the cytoplasmic domain. The truncated Env was more highly expressed on the cell surface, induced higher antibody responses than the full-length Env, reacted with HIV neutralizing monoclonal antibodies and mediated CD4/co-receptor-dependent fusion. Intramuscular (i.m.), intradermal (i.d.) needleless, and intrarectal (i.r.) catheter inoculations gave comparable serum IgG responses. However, intraoral (i.o.) needleless injector route gave the highest IgA in lung washings and i.r. gave the highest IgA and IgG responses in fecal extracts. Induction of CTL responses in the spleens of individual mice as assayed by intracellular cytokine staining was similar with both the full-length and truncated Env constructs. Induction of acute and memory CTL in the spleens of mice immunized with the truncated Env construct by i.d., i.o., and i.r. routes was comparable and higher than by the i.m. route, but only the i.r. route induced CTL in the gut-associated lymphoid tissue. Thus, truncation of Env enhanced genetic stability as well as serum and mucosal antibody responses, suggesting the desirability of a similar modification in MVA-based candidate HIV vaccines.

摘要

在编码HIV 89.6 Env的安卡拉改良痘苗病毒(MVA)传播过程中,有几个病毒病灶染色非常明显。从这些病灶克隆的病毒比亲本病毒复制到更高滴度,并且在传代时显示出增强的遗传稳定性。序列分析表明,突变体的89.6 env基因中有一个单核苷酸缺失,导致移码并从细胞质结构域截短了115个氨基酸。截短的Env在细胞表面表达更高,诱导的抗体反应比全长Env更高,与HIV中和单克隆抗体反应,并介导CD4/共受体依赖性融合。肌肉内(i.m.)、皮内(i.d.)无针和直肠内(i.r.)导管接种产生的血清IgG反应相当。然而,口腔内(i.o.)无针注射途径在肺灌洗液中产生的IgA最高,直肠内接种在粪便提取物中产生的IgA和IgG反应最高。通过细胞内细胞因子染色检测,在个体小鼠脾脏中诱导的CTL反应在全长和截短的Env构建体中相似。通过皮内、口腔内和直肠内途径用截短的Env构建体免疫的小鼠脾脏中,急性和记忆CTL的诱导相当,且高于肌肉内途径,但只有直肠内途径在肠道相关淋巴组织中诱导CTL。因此,Env的截短增强了遗传稳定性以及血清和粘膜抗体反应,这表明在基于MVA的候选HIV疫苗中进行类似修饰是可取的。